May 19, 2024 — A physician-initiated prospective, randomized clinical trial sponsored by the National Heart, Lung, and ...
May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ...
May 18, 2024 — The Heart Rhythm Society (HRS) has announced the findings of three new studies demonstrating the safety ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results ...
May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled ...
May 17, 2024 — Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced ...
May 16, 2024 — A recent publication in the American Heart Association Circulation highlights a comprehensive ...
May 16, 2024 — A new University of Cincinnati study provides more insight into how few patients have severe ischemic ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care ...
May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the ...
May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
In the dynamic realm of healthcare technology, cardiovascular information systems (CVIS) stand at the forefront ...
May 15, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott is recalling the HeartMate 3 LVAS by ...
May 14, 2024 — One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the ...